All You Need To Know About Coronavirus Vaccine Update
While some researchers have progressed to advanced stages of trials, some have already put out a time frame for the release of the corona vaccine. You will be surprised to know that countries have begun to take the special rights for vaccines even before it has been put in function for vaccination.
Since months many researchers have committed to come up with covid19 vaccines and now that we are about to reach the month of July, what are we up to? How close are we to get saved from this virus and how much more time we will need to save ourselves from being affected? The search for a coronavirus vaccine has reached its zenith. While some researchers have progressed to advanced stages of trials, some have already put out a time frame for the release of the corona vaccine.
You will be surprised to know that countries have begun to take the special rights for vaccines even before it has been put in function for vaccination.
Moderna is planning for phase 3 of trial in July and is hiring 30,000 people for this project. They are excited about phase 3 and believe that they will have the vaccine ready by thanksgiving and will be commercial by next year. CEO Stephane Bancel says, "We are very, very interested in knowing as much as we can about this vaccine and to ensure it is safe, This was the 10th vaccine that we put in a clinical trial. We've learned a lot over the years: how to optimize the manufacturing process, how to optimize your chemistry, to get the best vaccine we could,"
ALSO READ: Is Corona Right Time For Starting New Business?
Astra Zeneca by Oxford
The company has already begun with the human trials and if everything goes well they can deliver the candidate by October. They believe this vaccine can save humans from covid19 for almost a year.
CureVac AG by Germany
The company has got approval to conduct a trial on 168 health people and assumes that by mid-2021 they will be able to bring it in the market. Klaus Cichutek, President of German vaccine regulator PEI said that the company might be able to apply for approval by early 2021.
Imperial College, London
The imperial college has already begun with human trials which is important to know the results of its efficacy and safety. They are hoping to have available candidates by April 2021 "From a scientific perspective, new technologies mean we have been able to get moving on a potential vaccine with unprecedented speed. We've been able to produce a vaccine from scratch and take it to human trials in just a few months - from code to candidate - which has never been done before with this type of vaccine," said Professor Robin Shattock from the Department of Infectious Disease at Imperial College.
The United States does not need more widespread lockdowns to bring its COVID-19 outbreak under control, even though the national daily infection rate has stayed flat, leading government expert Anthony Fauci said Thursday. He also added he was optimistic the world would soon have a vaccine that would end the pandemic, calling early trial results "encouraging."
However, given it works by suppressing the abnormal immune response that damages the body's organs, rather than attacking the virus, Fauci cautioned it should not be prescribed too soon after a person was infected.
"This is perfectly compatible with knowing that early on in infection, you need the immune system to suppress the virus."